Special Issue "Nucleic Acids in Cancer Diagnosis and Therapy"
Deadline for manuscript submissions: 31 August 2021.
Shenzhen University International Cancer Center, Building A1-107, Shenzhen University Xili Campus, 1066 Xili Xueyuan Ave, Nanshan District, Shenzhen, Guangdong, China
Interests: noncoding RNA; microRNA; lncRNA; p53; MYC
Cancer research has been focused on the coding genes occupying 1%–2% of the human genome. Moreover, the cancer research in the coding genes has been concentrated on their genetic mutations and protein activities/functions. Since the functions of noncoding RNAs in cancer have been revealed, cancer researchers are expanding their focus from the 1%–2% coding genes to the 98%–99% noncoding transcripts of the human genome. As a result, a number of noncoding RNAs and their functional mechanisms have been identified and characterized in most types of cancer. Meanwhile, the scientific view of DNA and RNA as generators or products of proteins has changed. Many scientists have started to look at and focus on the function and potential of DNA and RNA as nucleic acids. So, the increasing research interest in nucleic acids has spontaneously increased the research interest in the functions and mechanisms of nucleic acids featuring RNA-binding proteins, RNA modifications, cell-free circulating DNA/RNA, and unique types of RNA such as tRNA fragments and circular RNAs.
In this Special Issue, articles about the potential of nucleic acids in cancer diagnosis and therapeutics are welcome.
Dr. Taewan Kim
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- noncoding RNA
- RNA-binding protein
- circular RNA
- tRNA fragment
- cell-free DNA
- cell-free RNA
- RNA editing and modification